Effects of exercise intervention to improve body composition and chemerin in middle-aged overweight women
الموضوعات : Journal of Physical Activity and HormonesMohsen Salesi 1 , Shakiba Gani 2
1 - Associate Professor in Exercise Physiology, Department of exercise sciences, College of Education, Shiraz University, Shiraz, Iran.
2 - Instructor, Department of exercise sciences, College of Education, Shiraz University, Shiraz, Iran.
الکلمات المفتاحية: body composition, Chemerin, Rhythmic exercise, Overweight women,
ملخص المقالة :
Introduction: There is well documented evidence that obesity are serious worldwide public health problems which result an increased risk of developing diseases such as, cardiovascular diseases and diabetes mellitus and regular exercises can be effective in preventing and treating such diseases. Chemerin, is a recently identified adipose tissue secreted hormone that has been shown to be elevated in obese individuals and associated with some components of the metabolic syndrome, including: the waist circumference, body mass index (BMI), fat percent, triglycerides and high-density lipoprotein. Thus, the aim of current study was to analyze the effect of rhythmic aerobic exercise training on serum chemerin and body composition components in overweight women. Material & methods: Twenty-four overweight women (BMI between 25 to 30 kg/m2) voluntarily participated in the study (12 subjects in each groups). Training groups participated in a rhythmic exercise training program for eight weeks, three times a week with 50-70 heart rpm for 60-90 minutes. The chemerin levels and body composition components were measured in the both groups pre and post training duration. Results: The serum chemerin levels were significantly decreased from 218.7 ± 7.6 to 190.3 ± 9.2 ng/mL (P<0.01) after training program. Weight and BMI, also, in exercise group was significantly decreased in compare with control after 8 weeks of exercise. Conclusions: Rhythmically exercise training were found to improve the serum chemerin levels and some components of body composition; thus, it could be effective in preventing obesity-related diseases and enhancing body composition of middle aged overweight women.
References
1. Ogden CL, Carroll MD , Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012, JAMA 2014; 311: 806-814.
2. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280: E827- E847.
3. Ntaios G, Gatselis NK, Makaritsis K, Dalekos GN: Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis 2013; 227: 216-221.
4. Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139.
5. Teta D, Adipokines as uremic toxins. J Ren Nutr 2012; 22: 81-85.
6. Fatima SS, Rehman R, Baig M, Khan TA. New roles of the multidimensional adipokine: chemerin, Peptides 2014; 62: 15-20.
7. Jialal I, Devaraj S, Kaur H. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab 2013; 98: E514-E517.
8. Wang D, Yuan GY, Wang XZ, Jia J, Di LL, Yang L, et al. Plasma chemerin level in metabolic syndrome. Genet Mol Res 2013; 12: 5986-5991.
9. Weigert J, Neumeier M, Wanninger J. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010; 72: 342-348.
10. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010; 95: 2892-2896.
11. Chen HY, Lin CC, Chiu YL, Hsu SP, Pai MF, Yang JY, et al. Serum fetuina and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One 2012; 7: 1-9.
12. Roman AA, Parlee SD, Sinal CJ. Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine 2012; 42: 243-251.
13. Bozaoglu K, Segal D, Shields K, Cummings N, Curran JE, Comuzzie AG, et al. Chemerin is associated with metabolic syndrome phenotypes in a mexican-american population. J Clin Endocrinol Metab 2009; 94: 3085-3088.
14. Blüher M, Rudich A, Klöting N, Golan R, Henkin Y, Rubin E, et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012; 35: 342-349.
15. Goralski K, McCarthy T, Hannimann E, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin: a novel sadipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007; 282: 28175-28188.
16. Catenacci VA, Grunwald GK, Ingebrigtsen JP. Physical activity patterns using accelerometry in the National Weight Control Registry. Obesity (Silver Spring) 2011; 19: 1163-1170.
17. Donnelly JE, Smith B, Jacobsen DJ, Kirk E, Dubose K, Hyder M, et al. The role of exercise for weight loss and maintenance, Best Pract. Res Clin Gastroenterol 2004; 18: 1009-1029.
18. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al., American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43: 1334-1359.
19. Doucet E, King N, Levine JA, Ross R. Update on exercise and weight control. J Obes. 2011; 2011: 358205.
20. Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metab Clin Exp 2012; 61: 706714.
21. Saremi A, Shavandi N, Parastesh M, Daneshmand H. Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in over-weight and obese men. Asian J Sports Med 2010; 3: 151-158.
22. Sutton-Tyrrell K, Zhao X, Santoro N, Lasley B, Sowers M, Johnston J, et al. Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol 2010; 171: 1203-1213.
23. Miller MB, Pearcey GEP, Cahill F, Mccarthy H, Stratton SBD, Nof- tall JC, et al. The effect of a short-term high-intensity circuit training program on work capacity, body composition, and blood profiles in sedentary obese men: a pilot study. Biomed Res Int 2014; 2014: 191797.
24. Kemmler W, Von Stengel S, Engelke K, Kalender W. Exercise decreases the risk of metabolic syndrome in elderly females. Med Sci Sport Exerc 2009; 41: 297.
25. ACSM. American College of Sports Medicine position stand. Pro-gression models in resistance training for healthy adults. Med Sci Sports Exerc 2009; 41: 687-708.
26. Heyward VH. Advanced fitness assessment and exercise prescription, 6th ed, Champaign, IL: Human Kinetics 2010; 301-324.
27. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003; 198: 977-985.
28. Stefanov T, Blüher M, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, et al. Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine 2014; 45: 382-391.
29. Lee MK, Chu SH, Lee DC, An KY, Park JH, Kim DI, et al. The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults. Clin Chim Acta 2013; 5:109-115.
